A detailed history of Bay Colony Advisory Group, Inc D transactions in Pfizer Inc stock. As of the latest transaction made, Bay Colony Advisory Group, Inc D holds 57,325 shares of PFE stock, worth $1.48 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
57,325
Previous 61,855 7.32%
Holding current value
$1.48 Million
Previous $1.73 Million 4.16%
% of portfolio
0.26%
Previous 0.3%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$27.7 - $31.39 $125,481 - $142,196
-4,530 Reduced 7.32%
57,325 $1.66 Million
Q2 2024

Jul 24, 2024

SELL
$25.26 - $29.6 $114,402 - $134,058
-4,529 Reduced 6.82%
61,855 $1.73 Million
Q1 2024

Apr 30, 2024

BUY
$25.89 - $29.73 $672,104 - $771,790
25,960 Added 64.22%
66,384 $1.84 Million
Q4 2023

Jan 29, 2024

SELL
$26.13 - $33.94 $976,164 - $1.27 Million
-37,358 Reduced 48.03%
40,424 $1.16 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $273,342 - $319,510
8,518 Added 12.3%
77,782 $2.58 Million
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $52,699 - $60,971
1,459 Added 2.15%
69,264 $2.54 Million
Q1 2023

Apr 27, 2023

SELL
$39.39 - $51.28 $92,724 - $120,713
-2,354 Reduced 3.36%
67,805 $2.77 Million
Q4 2022

Feb 01, 2023

SELL
$41.75 - $54.5 $130,635 - $170,530
-3,129 Reduced 4.27%
70,159 $3.6 Million
Q3 2022

Oct 27, 2022

SELL
$43.76 - $53.42 $161,518 - $197,173
-3,691 Reduced 4.79%
73,288 $3.21 Million
Q2 2022

Aug 08, 2022

SELL
$46.53 - $55.17 $169,927 - $201,480
-3,652 Reduced 4.53%
76,979 $3.89 Million
Q1 2022

Apr 28, 2022

BUY
$45.75 - $56.69 $855,067 - $1.06 Million
18,690 Added 30.17%
80,631 $4.17 Million
Q4 2021

Jan 28, 2022

BUY
$41.32 - $61.25 $255,853 - $379,260
6,192 Added 11.11%
61,941 $3.66 Million
Q3 2021

Nov 02, 2021

BUY
$39.25 - $50.42 $381,156 - $489,628
9,711 Added 21.09%
55,749 $2.4 Million
Q2 2021

Jul 22, 2021

BUY
$35.91 - $40.68 $116,922 - $132,454
3,256 Added 7.61%
46,038 $1.8 Million
Q1 2021

May 13, 2021

BUY
$33.49 - $37.77 $194,610 - $219,481
5,811 Added 15.72%
42,782 $1.55 Million
Q4 2020

Feb 02, 2021

SELL
$33.47 - $42.56 $56,463 - $71,798
-1,687 Reduced 4.36%
36,971 $1.36 Million
Q3 2020

Nov 25, 2020

BUY
$31.75 - $37.25 $377,507 - $442,902
11,890 Added 44.42%
38,658 $1.42 Million
Q2 2020

Jul 23, 2020

BUY
$30.12 - $36.54 $202,466 - $245,621
6,722 Added 33.53%
26,768 $875,000
Q1 2020

Apr 17, 2020

BUY
$27.03 - $38.62 $190,399 - $272,039
7,044 Added 54.18%
20,046 $654,000
Q4 2019

Jan 28, 2020

SELL
$32.92 - $37.36 $795,248 - $902,505
-24,157 Closed
0 $0
Q4 2019

Jan 28, 2020

BUY
$32.92 - $37.36 $428,025 - $485,754
13,002 New
13,002 $523,000
Q3 2019

Oct 25, 2019

BUY
$32.49 - $42.13 $398,912 - $517,272
12,278 Added 103.36%
24,157 $868,000
Q2 2019

Jul 17, 2019

BUY
$36.98 - $41.52 $12,314 - $13,826
333 Added 2.88%
11,879 $515,000
Q1 2019

Apr 30, 2019

BUY
$37.5 - $41.2 $30,300 - $33,289
808 Added 7.52%
11,546 $488,000
Q4 2018

Jan 29, 2019

BUY
$38.47 - $43.86 $42,855 - $48,860
1,114 Added 11.58%
10,738 $469,000
Q3 2018

Nov 05, 2018

BUY
$34.47 - $41.81 $51,084 - $61,962
1,482 Added 18.2%
9,624 $424,000
Q2 2018

Aug 09, 2018

BUY
$32.98 - $35.16 $268,523 - $286,272
8,142 New
8,142 $295,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Bay Colony Advisory Group, Inc D Portfolio

Follow Bay Colony Advisory Group, Inc D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bay Colony Advisory Group, Inc D, based on Form 13F filings with the SEC.

News

Stay updated on Bay Colony Advisory Group, Inc D with notifications on news.